OLOBION, S.L. (Unipersonal)

oloBion, S.L. (Unipersonal) is a science-based contract research and analytical services laboratory specializing in multi-omics disciplines, with headquarters at the Parc Científic de Barcelona (Barcelona Science Park) in Barcelona, Spain, and additional presence in the United States through a New York office and a collaborative laboratory at the UC Davis Genome Center in Davis, California. Founded in 2020, oloBion has grown to serve more than 1,000 researchers and organizations across academia and industry in over 30 countries, with an average project turnaround of approximately two weeks. The company's mission is to transform complex molecular data into actionable scientific knowledge, supporting life science innovation from fundamental research through applied product and technology development.

oloBion's primary analytical services are built around advanced mass spectrometry platforms, with liquid chromatography–tandem mass spectrometry (LC-MS/MS) equipped with Ion Mobility and high-resolution detection at the core of their workflows. Metabolomics services encompass both untargeted and targeted metabolic profiling, enabling comprehensive identification and quantification of small-molecule metabolites in biological matrices. These workflows are applied to drug mechanism-of-action studies, disease biomarker discovery, pharmacometabolomics, and ADME-related metabolite profiling. Sample types include plasma, serum, urine, tissue, cells, and plant or food matrices, processed through standardized and customized sample preparation protocols prior to LC-MS/MS acquisition.

Lipidomics is another core discipline at oloBion, covering the comprehensive analysis of lipid classes and molecular species across the lipidome. Services include lipid profiling for disease research models spanning dyslipidemia, cardiovascular disease, neurodegeneration, and oncology; lipid target discovery for pharmaceutical programs; lipid biomarker research; and cell membrane lipid composition analysis to assess drug-induced changes in membrane structure and lipid-driven cellular processes. The laboratory's lipidomics scientific advisory is led by Kim Ekroos, President of the International Lipidomics Society and founder of Lipidomics Consulting Ltd., reflecting the team's deep positioning within international lipidomics research.

Proteomics services complement the metabolomics and lipidomics offering, enabling protein-level characterization of biological systems and supporting therapeutic target identification, protein biomarker discovery, and mechanistic studies. In addition to these core disciplines, oloBion provides specialized analyses including Olink® proximity extension assay–based protein quantification, ionomics (elemental analysis of biological systems), caroteomics (carotenoid profiling), and nutritional analysis services. ADME–DMPK (absorption, distribution, metabolism, and elimination / drug metabolism and pharmacokinetics) bioanalytical workflows are also offered to support preclinical pharmacokinetics studies, helping pharmaceutical research teams assess compound exposure, metabolic stability, and biological response in non-clinical settings.

Underpinning all analytical workflows is oloMAP, oloBion's proprietary AI-powered bioinformatics and data analysis platform. oloMAP automates data processing from raw instrument output through statistical analysis, pathway enrichment, and biological interpretation, drawing on a proprietary database of more than one million annotated biomolecules. The platform delivers interactive visualization and reporting tools that allow clients to explore omics datasets and extract clear, data-driven conclusions without requiring deep bioinformatics expertise in-house. This integrated end-to-end approach—from sample preparation through interpreted results—differentiates oloBion as a full-service omics partner rather than a purely analytical laboratory.

oloBion serves a broad range of life science sectors. In pharmaceuticals and biotechnology, the laboratory supports drug discovery, preclinical research, biomarker programs, and translational R&D. In biomedical and health research, multi-omics profiling supports mechanistic and disease-association studies. The agriculture and food science sector benefits from metabolomics and lipidomics of plant, microbial, and food matrices, while cosmetics and dermatology clients leverage skin omics workflows to characterize product effects on skin biology. Nutraceutical and nutrition companies use nutritional analysis and metabolomics to characterize supplements and dietary interventions. Veterinary and animal science programs rely on the same core omics platforms, and environmental and ecology researchers apply exposomics and metabolomics approaches to assess environmental exposures and ecosystem health.

oloBion's scientific leadership combines decades of cumulative experience in metabolomics, lipidomics, and systems biology, with contributions to hundreds of peer-reviewed publications and internationally recognized methodological advances. The scientific advisory board includes Oliver Fiehn, Professor at the UC Davis Genome Center and Director of the West Coast Metabolomics Center, one of the foremost metabolomics authorities globally; Kim Ekroos in lipidomics; Andrea Petretto for clinical proteomics; and domain specialists in agriculture, microbiology, and clinical metabolomics. The core team is led by CEO and founder Paolo Bonini, with Chief Scientific Officer Lorenzo Torreni and Chief Technology Officer Sajjan Singh Mehta overseeing scientific and technology strategy respectively. This combination of expert personnel, advanced instrumentation, AI-driven data analysis, and a proprietary biomolecule database positions oloBion as a credible and capable multi-omics research partner for organizations seeking high-confidence analytical results.